These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 16773629

  • 21. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
    Freiha F, Reese J, Torti FM.
    J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
    [Abstract] [Full Text] [Related]

  • 22. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT, Arcangeli G, Cruciani E, Altavista P, Mecozzi A, Saracino B, Orefici F.
    Cancer; 2004 Dec 01; 101(11):2540-8. PubMed ID: 15481058
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The D allele of angiotensin-converting enzyme polymorphism as a predictor of renal function decline over 4 years in an apparently healthy Chinese population aged 60 and older.
    Lee YT, Chiu HC, Su HM, Voon WC, Lin TH, Lai WT, Sheu SH.
    J Am Geriatr Soc; 2008 Apr 01; 56(4):718-23. PubMed ID: 18284535
    [Abstract] [Full Text] [Related]

  • 25. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.
    Segal R, Winquist E, Lukka H, Chin JL, Brundage M, Markman BR, Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group.
    Can J Urol; 2002 Oct 01; 9(5):1625-33. PubMed ID: 12431323
    [Abstract] [Full Text] [Related]

  • 26. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy.
    Lehmann J, Retz M, Stöckle M.
    World J Urol; 2002 Aug 01; 20(3):144-50. PubMed ID: 12196897
    [Abstract] [Full Text] [Related]

  • 27. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
    Spruill WJ, Wade WE, Cobb HH.
    Am J Geriatr Pharmacother; 2008 Aug 01; 6(3):153-60. PubMed ID: 18775390
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of creatinine-based estimates of glomerular filtration rate in a large cohort of living kidney donors.
    Issa N, Meyer KH, Arrigain S, Choure G, Fatica RA, Nurko S, Stephany BR, Poggio ED.
    Transplantation; 2008 Jul 27; 86(2):223-30. PubMed ID: 18645483
    [Abstract] [Full Text] [Related]

  • 29. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.
    Urology; 2004 Sep 27; 64(3):488-93. PubMed ID: 15351577
    [Abstract] [Full Text] [Related]

  • 30. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index.
    Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A.
    Am J Kidney Dis; 2005 Aug 27; 46(2):233-41. PubMed ID: 16112041
    [Abstract] [Full Text] [Related]

  • 31. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
    Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E, Novara G, Raman JD, Lotan Y, Weizer A, Roupret M, Pycha A, Scherr DS, Seitz C, Ficarra V, Trinh QD, Karakiewicz PI, Montorsi F, Zerbib M, Shariat SF, UTUC Collaboration.
    BJU Int; 2013 Aug 27; 112(4):453-61. PubMed ID: 23464979
    [Abstract] [Full Text] [Related]

  • 32. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Aug 27; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 33. Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors.
    Angulo JC, Sanchez-Chapado M, Lopez JI, Flores N.
    J Urol; 1996 Jun 27; 155(6):1897-902. PubMed ID: 8618282
    [Abstract] [Full Text] [Related]

  • 34. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
    Calabrò F, Sternberg CN.
    Eur Urol; 2009 Feb 27; 55(2):348-58. PubMed ID: 18977070
    [Abstract] [Full Text] [Related]

  • 35. CKD-EPI and cockcroft-gault equations identify similar candidates for neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Pal SK, Ruel N, Villegas S, Chang M, DeWalt K, Wilson TG, Vogelzang NJ, Yuh BE.
    PLoS One; 2014 Feb 27; 9(4):e94471. PubMed ID: 24722472
    [Abstract] [Full Text] [Related]

  • 36. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N, Arima K, Sugimura Y.
    Int J Urol; 2008 Sep 27; 15(9):800-3. PubMed ID: 18651862
    [Abstract] [Full Text] [Related]

  • 37. Hypertension, microalbuminuria and renal dysfunction: the Renal Dysfunction in Hypertension (REDHY) study.
    Cerasola G, Mulè G, Cottone S, Nardi E, Cusimano P.
    J Nephrol; 2008 Sep 27; 21(3):368-73. PubMed ID: 18587725
    [Abstract] [Full Text] [Related]

  • 38. Difference of carboplatin clearance estimated by the Cockroft-Gault, Jelliffe, Modified-Jelliffe, Wright or Chatelut formula.
    Nagao S, Fujiwara K, Imafuku N, Kagawa R, Kozuka Y, Oda T, Maehata K, Ishikawa H, Koike H, Aotani E, Kohno I.
    Gynecol Oncol; 2005 Nov 27; 99(2):327-33. PubMed ID: 16005943
    [Abstract] [Full Text] [Related]

  • 39. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J, Franzaring L, Thüroff J, Wellek S, Stöckle M.
    BJU Int; 2006 Jan 27; 97(1):42-7. PubMed ID: 16336326
    [Abstract] [Full Text] [Related]

  • 40. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
    Sternberg CN.
    Semin Oncol; 2007 Apr 27; 34(2):122-8. PubMed ID: 17382795
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.